Vycor Medical designs, develops and markets medical devices for use in neurosurgery and provides FDA registered diagnostic and therapy products for vision disorders resulting from neurological brain injuries, self-described as offering innovative solutions.

Vycor Medical

NovaVision offers vision restoration therapy for stroke and traumatic brain injury patients, focusing on improving the range and sensitivity of their visual fields. It provides FDA-cleared therapies, including NeuroEyeCoach for vision compensation.

NovaVision

Vision Biotechnology specializes in developing and manufacturing diagnostic test kits for healthcare professionals to accurately diagnose various diseases. The company incorporates the latest advancements in biotechnology into its products, self-described as elevating healthcare through innovative testing solutions.

Vision Biotechnology

NOVAVISION provides comprehensive diagnostic and treatment services for ophthalmology, including corrective laser surgery, oculoplastic surgery, and facial rejuvenation, using advanced technology and specialized medical personnel.

NOVAVISION

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

Metric
Company Name	Vycor Medical	NovaVision	Vision Biotechnology	NOVAVISION
Symbol
MSH ID	COM:VYCORMEDICAL	COM:NOVAVISION	COM:VISIONBIOTECHNOLOGY	MX:COM:NOVAVISION
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Medical Devices	Medical Devices	Biotechnology	Medical Services
Country	US	US	US	MX
Stage
Employee Count
Website	vycormedical.com	novavision.com	visionbiotechnology.com	novavision.com.mx
LinkedIn			visionbiotechnolgy
Founders

Metric
Market Cap	2.93M
Enterprise Value
Monthly Web Traffic		434	2.59K
Web Traffic Growth		1.39	-0.17
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:VYCORMEDICAL

Vycor Medical

Last Close

0.05

22/11 20:00

Market Cap

2.93M

Beta: -

Volume Today

1K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue